Literature DB >> 19592102

Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study.

Cong Sun1, Ronald Klein, Tien Y Wong.   

Abstract

PURPOSE: To examine the associations of age-related macular degeneration (AMD) with incident coronary heart disease (CHD) and stroke in the Cardiovascular Health Study.
DESIGN: Population-based prospective cohort study. PARTICIPANTS: A total of 1786 white and African-American participants free of CHD or 2228 participants free of stroke, aged 69 to 97 years.
METHODS: AMD was evaluated from photographs taken in 1997 and 1998. MAIN OUTCOME MEASURES: Incident CHD and stroke ascertained using standardized methods.
RESULTS: Of the 1786 persons free of CHD, 303 developed incident CHD over 7 years. Participants with early AMD (n = 277) had a higher cumulative incidence of CHD than participants without early AMD (25.8% vs. 18.9%, P = 0.001). By adjusting for age, gender, race, systolic and diastolic blood pressure, hypertension status, fasting glucose, triglyceride, low-density lipoprotein cholesterol, cigarette smoking, pack years of smoking, and C-reactive protein, the presence of early AMD was associated with an increased risk of incident CHD (hazard ratio 1.57; 95% confidence interval, 1.17-2.22). Late AMD (n = 25) was not associated with incident CHD (hazard ratio 0.78; 95% confidence interval, 0.25-2.48). Among 2228 persons at risk, 198 developed incident stroke; neither early nor late AMD was associated with incident stroke.
CONCLUSIONS: This study suggests persons with early AMD have a higher risk of CHD but not stroke in a population aged 69 to 97 years. This provides further support that AMD is associated with underlying systemic vascular disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592102      PMCID: PMC3818148          DOI: 10.1016/j.ophtha.2009.03.046

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  42 in total

1.  A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study.

Authors:  Isabella Kardys; Caroline C W Klaver; Dominiek D G Despriet; Arthur A B Bergen; André G Uitterlinden; Albert Hofman; Ben A Oostra; Cornelia M Van Duijn; Paulus T V M de Jong; Jacqueline C M Witteman
Journal:  J Am Coll Cardiol       Date:  2006-03-29       Impact factor: 24.094

Review 2.  The role of inflammation in the pathogenesis of age-related macular degeneration.

Authors:  Larry A Donoso; David Kim; Arcilee Frost; Alston Callahan; Gregory Hageman
Journal:  Surv Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 6.048

Review 3.  The eye in hypertension.

Authors:  Tien Yin Wong; Tien Wong; Paul Mitchell
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

4.  Hospitalized cardiovascular diseases in neovascular age-related macular degeneration.

Authors:  Bao-Anh Nguyen-Khoa; Earl L Goehring; Winifred Werther; Emily W Gower; Diana V Do; Judith K Jones
Journal:  Arch Ophthalmol       Date:  2008-09

5.  Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Gabriella Tikellis; Cong Sun; Ronald Klein; David J Couper; A Richey Sharrett
Journal:  Ophthalmology       Date:  2007-01       Impact factor: 12.079

Review 6.  Genetic susceptibility to myocardial infarction and coronary artery disease.

Authors:  Eric J Topol; Jonathan Smith; Edward F Plow; Qing K Wang
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

7.  APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis.

Authors:  M O McCarron; D Delong; M J Alberts
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

8.  Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study.

Authors:  Tien Yin Wong; Aruna Kamineni; Ronald Klein; A Richey Sharrett; Barbara E Klein; David S Siscovick; Mary Cushman; Bruce B Duncan
Journal:  Arch Intern Med       Date:  2006-11-27

9.  Age-related macular degeneration and risk for stroke.

Authors:  Tien Yin Wong; Ronald Klein; Cong Sun; Paul Mitchell; David J Couper; Hong Lai; Larry D Hubbard; A Richey Sharrett
Journal:  Ann Intern Med       Date:  2006-07-18       Impact factor: 25.391

10.  Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study.

Authors:  Michael D Knudtson; Barbara E K Klein; Ronald Klein
Journal:  Arch Ophthalmol       Date:  2006-02
View more
  26 in total

1.  Age-related macular degeneration and long-term risk of stroke subtypes.

Authors:  M Kamran Ikram; Paul Mitchell; Ronald Klein; A Rickey Sharrett; David J Couper; Tien Y Wong
Journal:  Stroke       Date:  2012-04-24       Impact factor: 7.914

2.  The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.

Authors:  L-Y Ngai; N Stocks; J M Sparrow; R Patel; A Rumley; G Lowe; G Davey Smith; Y Ben-Shlomo
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

3.  Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Antonio B Fernandez; Tien Y Wong; Ronald Klein; Dorothea Collins; Gregory Burke; Mary Frances Cotch; Barbara Klein; Mehran M Sadeghi; Jersey Chen
Journal:  Ophthalmology       Date:  2011-12-23       Impact factor: 12.079

4.  Influence of seasonal sunlight intensity and iris color on the anti-VEGF therapy for neovascular age-related macular degeneration.

Authors:  C Brockmann; T Brockmann; J Dawczynski
Journal:  Eye (Lond)       Date:  2013-08-02       Impact factor: 3.775

5.  Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome.

Authors:  Douglas A Jabs; Mark L Van Natta; Efe Sezgin; Jeong Won Pak; Ronald Danis
Journal:  Am J Ophthalmol       Date:  2015-03-11       Impact factor: 5.258

6.  Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.

Authors:  Arseniy P Yashkin; Paul Hahn; Frank A Sloan
Journal:  Ophthalmology       Date:  2016-08-11       Impact factor: 12.079

7.  Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration.

Authors:  Lauren A Dalvin; Matthew R Starr; Jackson E AbouChehade; Gena M Damento; Maria Garcia; Saumya M Shah; David O Hodge; Irene Meissner; Sophie J Bakri; Raymond Iezzi
Journal:  JAMA Ophthalmol       Date:  2019-05-01       Impact factor: 7.389

8.  Role of statins in the development and progression of age-related macular degeneration.

Authors:  Brian L VanderBeek; David N Zacks; Nidhi Talwar; Bin Nan; Joshua D Stein
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

9.  Evaluation of plasma vascular endothelial growth factor levels after intravitreal injection of ranibizumab and aflibercept for exudative age-related macular degeneration.

Authors:  Izumi Yoshida; Tomoaki Shiba; Hikari Taniguchi; Mao Takahashi; Takeyoshi Murano; Nobuyuki Hiruta; Yuichi Hori; Hdieaki Bujo; Takatoshi Maeno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-17       Impact factor: 3.117

10.  Does matrix metalloproteinase-3 polymorphism play a role in age-related macular degeneration in patients with myocardial infarction?

Authors:  Rasa Liutkevičienė; Diana Žaliaduonytė-Pekšienė; Dalia Žaliūnienė; Olivija Gustienė; Vytautas Jašinskas; Vaiva Lesauskaitė; Abdonas Tamošiūnas; Remigijus Žaliūnas
Journal:  Medicina (Kaunas)       Date:  2012       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.